Zoekresultaten - You searched for Collaborations

67 results

Industrial automation companies from Baden-Württemberg looking for collaborations

Read more

Ablynx proposes appointment of Mrs. Hilde Windels as a new independent director

Read more

Ablynx announces 2017 half year results and year-to-date business update

Read more

BioFIT 2017

Read more

GAMIAN-Europe & CMAST announce collaborative partnership

Read more

flanders.bio provides you with insights in the vibrant life sciences sector

Read more

CMAST is stepping into a strategic partnership with FlandersBio

Read more

MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence

Read more

ThromboGenics Achieves Important Milestone in the Development of THR-149

Read more

argenx reports first quarter 2017 financial results and provides business update

Read more

Bone Therapeutics strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors

Read more

Celyad obtains additional US patent for cancer treatment

Read more

Belgium showcases expertise on Immunotherapy at the world’s largest Biotechnology Conference – San Diego, June 19- 23, 2017

Read more

PersoMed Towers

Read more

Immunity for Health 2017

Read more

argenx reports second quarter business update and half-year 2017 financial results

Read more

flanders.bio's Healthcare Leaders Dinner

Read more

Mithra announces 2017 half year results

Read more

flanders.bio joins forces with FIT to support the internationalisation of Flanders’ economy

Read more

Imec Designs and Fabricates World-First Miniature Neural Probe for Simultaneous Recording of Multiple Brain Regions at Neuronal Resolution

Read more

Biocartis Group NV: BIOCARTIS Q3 2017 BUSINESS UPDATE

Read more

13th International Conference on Renewable Resources & Biorefineries

Read more

Ablynx announces warrant exercise

Read more

ABLYNX COMPLETES PATIENT RECRUITMENT IN ITS PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF aTTP

Read more

3th BMIC Congress

Read more

ABLYNX REPORTS FINANCIAL RESULTS FOR THE FIRST THREE MONTHS OF 2017 AND A YEAR-TO-DATE BUSINESS UPDATE

Read more

Ablynx to present at upcoming USA Investor Conferences

Read more

SLims by Genohm integrated with Pathomation’s PMA.core

Read more

Novel Nanobody to start clinical development in osteoarthritis - ablynx to receive €15 Million milestone payment

Read more

REGMED Europe

Read more

Internationalisation

Read more

Ablynx to present additional data for its anti-IL-6R nanobody, vobarilizumab, at the annual European Congress of Rheumatology

Read more

Ablynx initiates a single and multiple dose phase I study of caplacizumab in healthy Japanese subjects

Read more

Ablynx achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc., Kenilworth, New Jersey, USA

Read more

Publication in accordance with art. 14 of the Belgian Law regarding the publication of major shareholdings (the "transparancy law")

Read more

Ablynx & Sanofi enter into a strategic collaboration to develop nanobody product candidates

Read more

Ablynx announces warrant exercise

Read more

Ablynx receives fast track designation from the FDA for Caplacizumab for the treatment of acquired TTP

Read more

Ablynx announces warrant exercise

Read more

Ablynx will announce its 2017 half year results with webcast on 24 august 2017

Read more

Ablynx: publication in accordance with article 14 of the Belgian law regarding the publication of major shareholdings

Read more

Ablynx to present at upcoming investor conferences in London

Read more

Ablynx Announces Warrant Exercise

Read more

Ablynx announces positive topline results from the Phase III Hercules Study of Caplacizumab for the treatment of acquired TTP

Read more

Ablynx files registration statement for a proposed global offering

Read more

Ablynx - Publication in accordance with art.14 of the Belgian law of 2/05/2017 regarding the publication of major shareholdings (the "transparancy law")

Read more

Internationalisation

Read more

Ablynx - Publication in accordance with art.14 of the Belgian Law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy law")

Read more

Ablynx establishes subsidiary in the USA and appoints a general manager

Read more

Ablynx - Publication in accordance with art.14 of the Belgian Law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy law")

Read more

Ablynx announces launch of proposed global offering

Read more

Ablynx announces warrant exercise

Read more

Ablynx prices $200 million Initial Public Offering in the United States

Read more

Suspension of trading in Ablynx shares on Euronext Brussels

Read more

Ablynx - Notice in Relation to the Convertible bonds due May 2020

Read more

Ablynx announces full exercise of underwriters' option to purchase additional shares and end of stabilization period

Read more

Ablynx - Publication in accordance with §14 of the Belgian law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy" law)

Read more

Ablynx closes $200 Million Initial Public Offering in the United States

Read more

Ablynx - Correction of Publication in accordance with §14 of the Belgian law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy" law)

Read more

Ablynx - Publication in accordance with §14 of the Belgian law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy" law)

Read more

Ablynx - Publication in accordance with §14 of the Belgian law of 2/5/2007 regarding the publication of major shareholdings (the "transparancy" law) (1)

Read more

Ablynx to present at upcoming investor conferences in London and Paris

Read more

Ablynx: publication regarding the publication of major shareholdings

Read more

Ablynx closes on underwriters' option to purchase $30 million of additional shares in the U.S. initial public offering

Read more

Ablynx: publication regarding the publication of major shareholdings (the "transparancy law")

Read more

Ablynx: publication regarding the publication of major shareholdings (the "transparancy law")

Read more

Ablynx announces results for the first nine months of 2017 and a year-to-date business update

Read more